차의과학대학교
 
Home > 최보윤

최보윤

최보윤 교수

전공임상약학
연락처 031-850-9443 boyoon1@cha.ac.kr

학력

  • 서울대학교 약학대학, 약학사
  • 서울대학교 약학대학, 약학석사, 임상약학 전공
  • 서울대학교 약학대학, 약학박사, 임상약학 전공


    • [전문분야]
  • Real-world data analytics
  • Pharmacometrics
  • Pharmacogenomics
  • Drug safety evaluation
  • Pharmaceutical care service
  • Pharmacotherapy in hemato-oncologic disease

경력

  • (현) 차 의과학대학교 약학대학 조교수
  • (현) 한국임상약학회 총무위원
  • 서울대학교 약학대학 강사
  • 대구가톨릭대학교 약학대학 강사
  • 서울대학교 종합약학연구소 연구원
  • 서울대학교병원 혈액종양내과 임상약사
  • 서울대학교병원 약물안전센터 임상약사
  • 서울대학교병원 약제부 약사
  • 한국보건의료정보원 인증기준 자문위원


    • [기타]
  • Valid Board Certified Pharmacotherapy Specialist (BCPS), U.S.
  • 서울대학교 NLRL 연구센터 및 충남대학교 BK21 신의약사업단 우수연구상 수상
  • 한국임상약학회 젊은임상약과학자상 수상


    • [연구실소개]

    본 연구실은 보험청구자료 등의 빅데이터(Big data) 및 실사용자료(Real-world data) 분석, 그리고 약물계량학(Pharmacometrics) 및 약물유전체학(Pharmacogenomics) 연구를 통하여 약물치료의 유효성과 안전성을 극대화하기 위한 연구를 수행하고 있습니다. 특별히 혈액종양질환(hemato-oncologic disease)에 대한 연구를 중점적으로 수행하고 있습니다. 또한 환자중심 약물치료를 구현하기 위하여 임상약사의 약료서비스(pharmaceutical care)를 개발하고 표준화하기 위한 방안을 함께 연구 중입니다.

논문

  • [해외논문]
  • Hyun Jin Park, Boyoon Choi, Yun-Kyoung Song, Yoon-Jeong Oh, Eun Bong Lee, In-Wha Kim, and Jung Mi Oh. Association of Tumor Necrosis Factor Inhibitors with the Risk of Nontuberculous Mycobacterial Infection in Patients with Rheumatoid Arthritis: A Nationwide Cohort Study. Journal of Clinical Medicine. 2023 Sep 12;6998. Doi: https://doi.org/10.3390/jcm12226998
  • Boyoon Choi, Hyun Jin Park, Yun-Kyoung Song, Yoon-Jeong Oh, In-Wha Kim, and Jung Mi Oh. The Risk of Newly Diagnosed Cancer in Patients with Rheumatoid Arthritis by TNF Inhibitor Use: A Nationwide Cohort Study. Arthritis Research & Therapy. 2022 Aug 9;24(1):191. Doi: 10.1186/s13075-022-02868-w.
  • Yun-Kyoung Song, Boyoon Choi, Jung Mi Oh, Arim Kwak, Kyungim Kim. Employee Perspectives on Onsite Health Clinics in Semiconductor. International Journal of Environmental Research and Public Health. 2022 Oct; 19:1433. doi: 10.3390/ijerph19031433.
  • Yun-Kyoung Song†, Boyoon Choi†, Kyungim Kim, Hyun Jin Park, and Jung Mi Oh. Factors Influencing Workplace Health Promotion Interventions for Workers in the Semiconductor Industry According to Risk Levels of Chronic Disease. International Journal of Environmental Research and Public Health. 2021 Oct; 18(21):11383-11398. Doi: 10.3390/ijerph182111383.
  • Myeong Gyu Kim, Arim Kwak, Boyoon Choi, Eunhee Ji, Jung Mi Oh, and Kyungim Kim. Effect of glutathione S-transferase genetic polymorphisms on busulfan pharmacokinetics and veno-occlusive disease in hematopoietic stem cell transplantation: A meta-analysis. Basic & Clinical Pharmacology & Toxicology. 2019 Jun; 124(6):691-703. doi: 10.1111/bcpt.13185.
  • Yun-Kyoung Song, Jae Hyun Kim, Boyoon Choi, Nayoung Han, Myeong Gyu Kim, Jeongsam Lee, Handuk Lee, Jieun Yoon, Beom-Jin Lee, and Jung Mi Oh. Strategic Priorities to Improve Effectiveness of Anti-smoking Interventions for the Korean Military: An Application of the Analytic Hierarchy Process. Military Medicine. 2018 Jun; 183(7-8):e230. doi:10.1093/milmed/usx027.
  • Sohyun Jeong, Minji Sohn, Jae Hyun Kim, Minoh Ko, Hee-won Seo, Yun-Kyoung Song, Boyoon Choi, Nayoung Han, Han-Sung Na, Jong Gu Lee, In-Wha Kim, Jung Mi Oh and Euni Lee. Current globalization of drug interventional clinical trials: characteristics and associated factors, 2011–2013. Trials. 2017 Jun 21;18(1):288. doi: 10.1186/s13063-017-2025-1.
  • Sohyun Jeong, Nayoung Han, Boyoon Choi, Minji Sohn, Yun-Kyoung Song, Myeon-Woo Chung, Han-Sung Na, Eunhee Ji, Hyunah Kim, Ki Yon Rhew, Therasa Kim, In-Wha Kim, Jung Mi Oh. Construction of a database for published phase II/III drug intervention clinical trials for the period 2009-2014 comprising 2,326 records, 90 disease categories, and 939 drug entities. Int J Clin Pharmacol Ther. 2016 Jun;54(6):416-25. doi: 10.5414/CP202529.
  • Boyoon Choi, Myeong Gyu Kim, Nayoung Han, Therasa Kim, Eunhee Ji, Seonyang Park, In-Wha Kim, and Jung Mi Oh. Population pharmacokinetics and pharmacodynamics of busulfan with GSTA1 polymorphisms in patients undergoing allogeneic hematopoietic stem cell transplantation. Pharmacogenomics. 2015 Sep;16(14):1585-94. doi: 10.2217/pgs.15.98.
  • Myeong Gyu Kim, In-Wha Kim, Boyoon Choi, Nayoung Han, Hwi-Yeol Yun, Seongyang Park, and Jung Mi Oh, Population pharmacokinetics of cyclosporine in hematopoietic stem cell transplant patients: consideration of genetic polymorphisms. Ann Pharmacother: 2015 Jun;49(6):622-30. doi: 10.1177/1060028015577798.

  • [국내논문]
  • Sang-Bong Lee, Dong-Yeop Lee, Ji-Hyun Kim, Seung Hei Moon, Gwijin Lee, Boyoon Choi, Ye Seul Kim, Jae Hyoung Im and Dong Yoon Kang. Analysis of Treatment-Related Adverse Events in Hospitalized Patients with Coronavirus Disease 2019. Pharmacoepidemiology and Risk Management. 2023 Jun;15:128-136
  • Boyoon Choi, Ha Young Jang, Hye-Ryun Kang, and Jung Mi Oh. Hypersensitivity Reactions to Anticancer Monoclonal Antibodies. Pharmacoepidemiology and Risk Management. 2023 Mar; 15(1):1-10
  • Hyun Jin Park, Bo Yoon Choi, Minji Sohn, Na Young Han, In-Wha Kim, and Jung Mi Oh. Effects of Tumor Necrosis Factor-alpha Inhibitors on the Incidence of Tuberculosis. Korean J Clin Pharm. 2018 Dec; 28(4):333-341

저서/역서/편서